Brooks Laboratories Ltd Share Price
(BROOKS)
₹133.94
as on 04:01PM, 29 Apr 2025
Brooks Laboratories Ltd Performance
Day's Low
Day's High
₹133.2Day's Price Range₹13852 Week's Low
52 Week's High
₹73.2552-Week Price Range₹198.86
| Returns % | |
| 1 Month Return | + 20.94 % |
| 3 Month Return | -11.7 % |
| 1 Year Return | + 27.93 % |
| Market Stats | |
| Previous Close | ₹137.87 |
| Open | ₹134.50 |
| Volume | 11.52K |
| Upper Circuit | ₹144.76 |
| Lower Circuit | ₹130.97 |
| Market Cap | ₹394.55Cr |
Brooks Laboratories Ltd Fundamentals
P/E Ratio
-16.81
PEG Ratio
7.2
Market Cap
₹394.55 Cr
P/B Ratio
3.5
EPS
-7.46
Dividend Yield
0Sector
Pharmaceuticals
ROE
1.9
Mutual Fund Holdings of Brooks Laboratories Ltd
| Funds | Holdings | Prev. 5M |
|---|---|---|
 Quant Business Cycle Fund Direct Growth | 2.51% |
Key events for Brooks Laboratories Ltd
Brooks Laboratories Reports Q4 Loss Despite Sales Growth - 14 Feb, 2025
Brooks Laboratories reported a consolidated net loss of Rs 4.57 crore for the December 2024 quarter, an increase from a loss of Rs 3.88 crore in December 2023. However, sales surged by 76.78% to Rs 38.45 crore compared to Rs 21.75 crore in the previous year.
Insights on Brooks Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 18.0 Cr → 38.55 Cr (in ₹), with an average increase of 29.9% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.05% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, BROOKS stock has moved up by 24.5%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 52.62% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 87.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 22.0%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 37.48% to 36.95% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, -2.41 Cr → -4.57 Cr (in ₹), with an average decrease of 39.9% per quarter
Brooks Laboratories Ltd Financials
Brooks Laboratories Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 52.62% | 0.00 | |
| Foreign Institutions | 0.05% | 1907.41 | |
| Mutual Funds | 9.9% | 0.00 | |
| Retail Investors | 36.95% | ||
| Others | 0.48% | 0.00 |
Brooks Laboratories Ltd Key Indicators
Brooks Laboratories Ltd Valuation
Brooks Laboratories Ltd in the last 5 years
Lowest (-31.36x)
January 11, 2024
Today (-16.81x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (-5.43x)
May 25, 2023
Brooks Laboratories Ltd Earnings and Dividends
Brooks Laboratories Ltd Earnings Results
Brooks Laboratories Ltd’s net profit fell -17.78% since last year same period to ₹-4.57Cr in the Q3 2024-2025. On a quarterly growth basis, Brooks Laboratories Ltd has generated -15.4% fall in its net profits since last 3-months.
Read More about Earnings Results
Brooks Laboratories Ltd Technicals Summary
Bearish
Neutral
Bullish
Brooks Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Brooks Laboratories Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹394.55 Cr | 56.21% | 0.55 | -₹20 Cr | ₹79 Cr | |
| NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
| NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
| NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
| NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
About Brooks Laboratories Ltd
Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.
Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.
Revenue: ₹38.45Cr as on December 2024 (Q4 24)
Net Profit: ₹-4.57Cr as on December 2024 (Q4 24)
Listing date: 05 Sep, 2011
| Organisation | Brooks Laboratories Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Brooks Laboratories Ltd
What is Brooks Laboratories Ltd price today?
Brooks Laboratories Ltd share price today stands at ₹133.94, Open: ₹134.5, Previous Close: ₹137.87, High: ₹138, Low: ₹133.2, 52 Week High: ₹198.86, 52 Week Low: ₹73.25.
How to Buy Brooks Laboratories Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Brooks Laboratories Ltd shares
What are today's traded volumes of Brooks Laboratories Ltd?
Today's traded volume of Brooks Laboratories Ltd(BROOKS) is 11.52K.
What is today's market capitalisation of Brooks Laboratories Ltd?
Today's market capitalisation of Brooks Laboratories Ltd(BROOKS) is ₹394.55Cr.
What is the 52 Week High and Low Range of Brooks Laboratories Ltd?
How much percentage Brooks Laboratories Ltd is down from its 52 Week High?
Brooks Laboratories Ltd (BROOKS) share price is ₹133.94. It is down -32.65% from its 52 Week High price of ₹198.86
How much percentage Brooks Laboratories Ltd is up from its 52 Week low?
Brooks Laboratories Ltd (BROOKS) share price is ₹133.94. It is up 82.85% from its 52 Week Low price of ₹73.25